PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PrimeSyn Lab, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PrimeSyn Lab Expands Operation and Growth Prompts for Move to New Larger Quarters - PrimeSyn Lab, Inc. expands its operation and moves to a new location. The company provides contract lab services which focuses in the areas of Organic synthesis, GMP oligos, Analytical lab services, Proteins and educational services
PrimeSyn Lab Expands Operation and Growth Prompts for Move to New Larger Quarters

 

NewswireToday - /newswire/ - Hillsborough, NJ, United States, 2007/01/19 - PrimeSyn Lab, Inc. expands its operation and moves to a new location. The company provides contract lab services which focuses in the areas of Organic synthesis, GMP oligos, Analytical lab services, Proteins and educational services.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Since establishing the NJ operations in 2002, PrimeSyn Lab Inc. has grown considerably. "Our rapid expansion made us realize that we needed more space to meet our customer's needs and for future growth," said Dr. Chaturvedi, CEO, PrimeSyn Lab Inc. "We chose to locate our company within NJ to be readily available to our bio-pharmaceutical customers. With our new expanded operation, we feel we can support our customers and help them achieve their goals faster and more effectively."

Dr. Chaturvedi looks forward to expanding their laboratory educational offerings in their new facility, which houses a modern state of the art training center located at 9 Ilene Ct. Bldg 6, Unit 1 and 2 Hillsborough, NJ 08844.

About PrimeSyn Lab, Inc.

PrimeSyn Lab (primesyn.com) is a leader in the area of Custom DNA/RNA primer and probe synthesis and specializes in ULTRA PURE Oligonucleotides. PrimeSyn Lab is a FDA registered manufacturer for Analyte Specific Reagents (ASRs) and can provide GMPs custom oligo synthesis. PrimeSyn Lab also provides contract analytical lab services (e.g. including structural characterization of protein molecules, CD and fluorescent spectroscopy, mass spectral analysis, and small molecule analysis). Our expertise spans organic synthesis and analysis through method development. PrimeSyn Lab's products and services are used for contract research, product development and assay development within the Bio-pharmaceutical industry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PrimeSyn Lab, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


PrimeSyn Lab Expands Operation and Growth Prompts for Move to New Larger Quarters

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Corporate Affairs - PrimeSyn.com 
1-877-PRIME03 press[.]primesyn.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PrimeSyn Lab, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PrimeSyn Lab, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)